GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

ECO Animal Health Group EAH.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

81.00p

-2.99%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About ECO Animal Health Group

Its shares trade on LSE under the ticker EAH.L. It has been listed since 26 September 1995. In the fiscal year to 31 March 2026, it reported revenue of £87.5m and net income of £2.2m. At that date it held total assets of £118.6m and shareholders' equity of £87.1m.

ECO Animal Health Group Plc engages in the development, registration and marketing of pharmaceutical products for animals. The company is headquartered in New Malden, Surrey. The firm's principal activity is the manufacture and supply of animal health products across the globe. These activities are conducted on a global scale, through a network, including both regional offices (notably in Shanghai and Princeton) and overseas subsidiaries. The firm's products include Aivlosin and Ecomectin. Aivlosin is an antibiotic that treats a range of specific enteric (gut) and respiratory diseases in pigs and poultry. Ecomectin is an endectocide that controls worms, ticks, lice and mange in grazing stock and pigs. The company operates in the United Kingdom and Europe, the Far East, Latin America, North America, and the Middle East and Africa. Its subsidiaries include Eco Animal Health Limited and ECO Animal Health do Brasil Comercio de Produtos Veterinarios Ltda.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
26 Sept 1995
Employees
204

Leadership

Pay as last reported

  • Dr. Joachim HasenmaierIndependent Non-Executive Chairman of the Board£47,000
  • Mr. David HallasChief Executive Officer, Executive Director, since 2022£431,000
  • Mr. Christopher WilksChief Financial Officer, Executive Director, Company Secretary, since 2019£367,000
  • Dr. Frank ArmstrongIndependent Non-Executive Director£53,000
  • Ms. Tracey JamesIndependent Non-Executive Director£53,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
43
Environment
41
Social
32
Governance
57
Direct emissions (scope 1)
11 t
Energy emissions (scope 2)
9 t
Women in the workforce
44%
Carbon reduction policy
No
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • ECO Animal Health Group PLC has established a strong presence in the animal health industry, allowing it to capture a significant share of the market. This market presence provides the company with a competitive advantage and enhances its brand reputation.
  • The company offers a wide range of high-quality animal health products that cater to various animal species and health conditions. This diverse product portfolio enables ECO Animal Health Group PLC to meet the diverse needs of its customers and stay ahead of the competition.

Weaknesses

  • ECO Animal Health Group PLC heavily relies on a few key markets for its revenue. Any negative developments or disruptions in these markets could significantly impact the company's financial performance and stability.
  • While the company has a strong market presence in its key markets, it has limited global reach compared to some of its competitors. This limited reach may hinder its ability to fully capitalize on international growth opportunities and expand its customer base.

Opportunities

  • The global demand for animal health products is on the rise due to factors such as population growth, increasing pet ownership, and growing concerns about animal welfare. ECO Animal Health Group PLC can take advantage of this trend by expanding its product offerings and targeting new markets.
  • Rapid technological advancements present opportunities for ECO Animal Health Group PLC to develop innovative products and solutions. Embracing new technologies can not only improve the company's efficiency and productivity but also differentiate it from competitors in the market.

Threats

  • The animal health industry is highly competitive, with numerous players vying for market share. ECO Animal Health Group PLC faces the risk of increased competition from both established companies and new entrants, which could potentially impact its market position and profitability.
  • Operating in the animal health sector requires compliance with strict regulations and standards imposed by regulatory bodies. Failure to adhere to these regulations can lead to legal issues, reputational damage, and potential market exclusion for ECO Animal Health Group PLC.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.